111 related articles for article (PubMed ID: 9468565)
1. Circulating levels of soluble intercellular adhesion molecule-1 in non-small cell lung cancer patients.
De Vita F; Infusino S; Auriemma A; Orditura M; Catalano G
Oncol Rep; 1998; 5(2):393-6. PubMed ID: 9468565
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of soluble intercellular adhesion molecule-1 (ICAM-1, CD54) in patients with non-small-cell lung cancer: correlation with histological expression of ICAM-1 and tumour stage.
Grothey A; Heistermann P; Philippou S; Voigtmann R
Br J Cancer; 1998 Mar; 77(5):801-7. PubMed ID: 9514061
[TBL] [Abstract][Full Text] [Related]
3. Increased serum levels of tumor necrosis factor-alpha are correlated to soluble intercellular adhesion molecule-1 concentrations in non-small cell lung cancer patients.
De Vita F; Orditura M; Infusino S; Auriemma A; Catalano G
Int J Mol Med; 1998 Mar; 1(3):605-8. PubMed ID: 9852272
[TBL] [Abstract][Full Text] [Related]
4. Serum IL-23, E-selectin and sICAM levels in non-small cell lung cancer patients before and after radiotherapy.
Kiziltunc Ozmen H; Simsek M
J Int Med Res; 2020 May; 48(5):300060520923493. PubMed ID: 32419551
[TBL] [Abstract][Full Text] [Related]
5. Soluble adhesion molecules E-cadherin, intercellular adhesion molecule-1, and E-selectin as lung cancer biomarkers.
Gogali A; Charalabopoulos K; Zampira I; Konstantinidis AK; Tachmazoglou F; Daskalopoulos G; Constantopoulos SH; Dalavanga Y
Chest; 2010 Nov; 138(5):1173-9. PubMed ID: 20495107
[TBL] [Abstract][Full Text] [Related]
6. Baseline levels and decrease in serum soluble intercellular adhesion molecule-1 during chemotherapy predict objective response and survival in patients who have advanced non-small-cell lung cancer.
Qian Q; Zhan P; Yu L; Shi Y; Cheng J; Wei S; Wang Q; Song Y
Clin Lung Cancer; 2011 Mar; 12(2):131-7. PubMed ID: 21550560
[TBL] [Abstract][Full Text] [Related]
7. Circulating intercellular adhesion molecule-1 in patients with lung cancer.
Taguchi O; Gabazza EC; Kobayashi T; Yoshida M; Yasui H; Kobayashi H
Intern Med; 1997 Jan; 36(1):14-8. PubMed ID: 9058094
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of the preoperative serum-soluble intercellular adhesion molecule-1 in non-small cell lung cancer.
Kamiyoshihara M; Kawashima O; Otani Y; Morishita Y
J Cardiovasc Surg (Torino); 2002 Oct; 43(5):729-34. PubMed ID: 12386593
[TBL] [Abstract][Full Text] [Related]
9. Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide.
Young RJ; Tin AW; Brown NJ; Jitlal M; Lee SM; Woll PJ
Br J Cancer; 2012 Mar; 106(6):1153-9. PubMed ID: 22353811
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of intercellular adhesion molecule ICAM-1 and E-selectin in advanced stage non-small cell lung cancer.
Guney N; Soydinc HO; Derin D; Tas F; Camlica H; Duranyildiz D; Yasasever V; Topuz E
Med Oncol; 2008; 25(2):194-200. PubMed ID: 18008189
[TBL] [Abstract][Full Text] [Related]
11. The relationship between the serum intercellular adhesion molecule-1 level and the prognosis of the disease in lung cancer.
Shin HS; Jung CH; Park HD; Lee SS
Korean J Intern Med; 2004 Mar; 19(1):48-52. PubMed ID: 15053044
[TBL] [Abstract][Full Text] [Related]
12. Soluble intercellular adhesion molecule-1 in patients with lung cancer and benign lung diseases.
Sprenger A; Schardt C; Rotsch M; Zehrer M; Wolf M; Havemann K; Heymanns J
J Cancer Res Clin Oncol; 1997; 123(11-12):632-8. PubMed ID: 9620222
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of interleukin-6 as a prognostic factor in advanced non-small cell lung cancer.
De Vita F; Orditura M; Auriemma A; Infusino S; Roscigno A; Catalano G
Oncol Rep; 1998; 5(3):649-52. PubMed ID: 9538169
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of serum concentrations of intercellular adhesion molecule-1 in patients with colorectal cancer.
Kang X; Wang F; Xie JD; Cao J; Xian PZ
World J Gastroenterol; 2005 Jul; 11(27):4250-3. PubMed ID: 16015700
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of serum intercellular adhesion molecule-1 (ICAM-1) in patients with non-small cell lung cancer.
Osaki T; Mitsudomi T; Yoshida Y; Oyama T; Ohgami A; Nakanishi K; Nakanishi R; Sugio K; Yasumoto K
Surg Oncol; 1996 Jun; 5(3):107-13. PubMed ID: 8908715
[TBL] [Abstract][Full Text] [Related]
16. Letter to the Editor: "Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy".
Nicolazzo C; Raimondi C; Loreni F; Gazzaniga P; Gradilone A
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629196
[TBL] [Abstract][Full Text] [Related]
17. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.
Chakra M; Pujol JL; Lamy PJ; Bozonnat MC; Quantin X; Jacot W; Daurès JP
J Thorac Oncol; 2008 Oct; 3(10):1119-26. PubMed ID: 18827607
[TBL] [Abstract][Full Text] [Related]
18. Treatment of unresectable nonsmall-cell lung cancer (NSCLC).
Papacharalambous A; Rigatos G; Alexopoulos A; Stavrakakis J; Scartsilas C; Stavrinidis E
J Chemother; 1989 Jul; 1(4 Suppl):1214-5. PubMed ID: 16312839
[No Abstract] [Full Text] [Related]
19. Reply to the Letter to the Editor by C. Nicolazzo et al.: "Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy".
Alama A; Coco S; Vanni I; Grossi F
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629197
[TBL] [Abstract][Full Text] [Related]
20. Soluble ICAM-1 levels in small-cell lung cancer: prognostic value for survival and predictive significance for response during chemotherapy.
Kotteas EA; Gkiozos I; Tsagkouli S; Bastas A; Ntanos I; Saif MW; Syrigos KN
Med Oncol; 2013; 30(3):662. PubMed ID: 23884579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
